| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total net revenue | $3.2M+19.0% | $2.7M | — | — |
| Total cost of net revenue | $1.7M-27.9% | $2.3M-58.5% | $5.5M+86.5% | $3.0M |
| Gross profit | $30.4M+7985.1% | $376K+110.9% | -$3.5M-975.2% | $395K |
| Research and development | $16.5M+111.0% | $7.8M+4.9% | $7.5M+4.4% | $7.1M |
| Sales and marketing | $11.3M+183.8% | $4.0M-23.2% | $5.2M-15.7% | $6.1M |
| General and administrative | $35.1M+261.0% | $9.7M+81.1% | $5.4M+4.1% | $5.2M |
| Total operating expenses | $62.9M+192.3% | $21.5M+19.5% | $18.0M-2.4% | $18.4M |
| Loss from operations | -$32.5M-53.6% | -$21.1M+1.5% | -$21.5M-18.9% | -$18.0M |
| Interest expense, net | -$20.0M-1470.9% | -$1.3M-36.5% | -$932K-3.8% | -$898K |
| Change in fair value of convertible notes | -$20.6M | — | — | — |
| Change in fair value of convertible note to related party | $97K | — | — | — |
| Change in fair value of warrant liability | $19K+100.1% | -$29.1M-745.7% | $4.5M+58.1% | $2.9M |
| Loss on debt extinguishment | -$5.8M | — | — | — |
| Other expense, net | -$239K-297.5% | $121K+12200.0% | -$1K+91.7% | -$12K |
| Loss before provision for income taxes | -$79.0M-53.6% | -$51.4M-174.7% | -$18.7M-15.9% | -$16.1M |
| Provision for income tax expense | $5K | — | $4K+100.0% | $2K |
| Net loss | -$79.0M-53.7% | -$51.4M-174.6% | -$18.7M-15.9% | -$16.2M |
| Deemed dividend on conversion of Series B preferred for common stock and repurchase of Series B preferred stock | -$5.8M | — | -$6.4M | — |
| Deemed dividend on issuance of common stock and warrants issued in connection with amendments to warrants to purchase common stock | -$10.5M | — | — | — |
| Net loss attributable to common stockholders | -$79.0M-16.6% | -$67.7M-170.0% | -$25.1M-55.3% | -$16.2M |
| Net loss per common share- basic (in dollars per share) | -$520.00+96.8% | -$16140.00-3288.5% | -$476.31-474.6% | -$82.89 |
| Net loss per common share- diluted (in dollars per share) | -$520.00+96.8% | -$16140.00-3288.5% | -$476.31-474.6% | -$82.89 |
| Weighted average number of common shares used in computing net loss per common share - Basic (in shares) | $152579525000.00+3535.2% | $4197284000.00+7971041.0% | $52656.00-73.0% | $194852.00 |
| Weighted average number of common shares used in computing net loss per common share - Diluted (in shares) | $152579525000.00+3535.2% | $4197284000.00+7971041.0% | $52656.00-73.0% | $194852.00 |
| Patent license | ||||
| Live events | ||||
| Consumer audio products, components, and other | ||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.